✦ LIBER ✦

Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol–fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE): a randomised, double-blind, parallel group study

✍ Scribed by Vogelmeier, Claus F; Bateman, Eric D; Pallante, John; Alagappan, Vijay KT; D'Andrea, Peter; Chen, Hungta; Banerji, Donald

Book ID: 121979761
Publisher: Elsevier
Year: 2013
Tongue: English
Weight: 423 KB
Volume: 1
Category: Article
ISSN: 2213-2600
DOI: 10.1016/S2213-2600(12)70052-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Analysis of chronic obstructive pulmonar

Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study

✍ Wedzicha, Jadwiga A; Decramer, Marc; Ficker, Joachim H; Niewoehner, Dennis E; Sa 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 345 KB

A randomized, double-blind, parallel-gro

A randomized, double-blind, parallel-group study to compare the efficacy and safety of a once-daily loratadine–pseudoephedrine combination with that of a twice-daily loratadine–pseudoephedrine combination in the treatment of allergic rhinitis

✍ Yen-An Chen; Kai-Ping Chang; Yaoh-Shiang Lin; Sheng-Po Hao 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 215 KB

Efficacy, safety, and effects on blood p

Efficacy, safety, and effects on blood pressure of naproxcinod 750 mg twice daily compared with placebo and naproxen 500 mg twice daily in patients with osteoarthritis of the hip: A randomized, double-blind, parallel-group, multicenter study

✍ Christoph Baerwald; Paolo Verdecchia; Brigitte Duquesroix; Hayet Frayssinet; Thi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 372 KB 👁 3 views

Efficacy and safety of once daily elvite

Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: randomised, double-blind, phase 3, non-inferiority study

✍ Jean-Michel Molina; Anthony LaMarca; Jaime Andrade-Villanueva; Bonaventura Clote 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 209 KB

The efficacy and safety of inhaled fluti

The efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: An eight-week, multicenter, randomized, double-blind, double-dummy, parallel-group study

✍ Barry Make; Nicola A. Hanania; Richard ZuWallack; Christopher Kalberg; Amanda Em 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 842 KB

Efficacy and safety of linagliptin 2.5 m

Efficacy and safety of linagliptin 2.5 mg twice daily versus 5 mg once daily in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, placebo-controlled trial

✍ Ross, Stuart A.; Rafeiro, Elizabeth; Meinicke, Thomas; Toorawa, Robert; Weber-Bo 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 254 KB